Colitis-associated colorectal cancer, which represents a highly aggressive subtypes of
colorectal cancer, requires concurrent antitumor and anti-inflammation therapies in clinic …

Tumor microenvironment (TME)‐responsive nanozyme‐catalyzed cancer therapy shows
great potential due to its specificity and efficiency. However, breaking the self‐adaption of …

Inflammatory disease (ID) is a general term that covers all diseases in which chronic
inflammation performs as the major manifestation of pathogenesis. Traditional therapies …

High concentrations of reactive oxygen and nitrogen species (RONS) are key characteristics
of inflammatory sites. Scavenging RONS at the site of inflammation is an effective …

Catalytic therapy employing nanozymes has evoked extensive exploration as a promising
regimen for cancer theranostics, with specific reactivity in response to tumor …

It is of great significance to eliminate excessive reactive oxygen species (ROS) for treating
inflammatory bowel disease (IBD). Herein, for the first time, a novel nanozyme NiCo2O4 …

Colitis-associated colorectal cancer (CAC), in which chronic inflammation is a well-
recognized carcinogen, requires concurrent anti-inflammation and antitumor treatments in …

Bacterial infections have become major threats to public health all over the world. With the
emergence of antibiotic resistance, it is urgent to develop novel antimicrobial materials to …

Specific generation of reactive oxygen species (ROS) within tumors in situ catalyzed by
nanozymes is a promising strategy for cancer therapeutics. However, it remains a significant …

Antibiotic‐independent artificial nanozymes exhibit excellent biocatalytic activity, and can
generate sufficient reactive oxygen species (ROS) for potential applications in the field of …